Asia-Pacific Endotoxin and Pyrogen Testing Market Industry Trends and Forecast to 2030

Asia-Pacific Endotoxin and Pyrogen Testing Market Industry Trends and Forecast to 2030

The Asia-Pacific endotoxin and pyrogen testing market is expected to reach USD 233,324.10 thousand by 2030 from USD 98,250.58 thousand in 2022, growing at a CAGR of 11.9% in the forecast period of 2023 to 2030.

Market Segmentation
Asia-Pacific Endotoxin and Pyrogen Testing Market, By Product Type (Detection Kits & Reagents, Instruments & Systems, Endotoxin and Pyrogen Testing Services, Consumables & Accessories), Test Type (Limulus Amoebocyte Lysate (LAL) Test, TAL Tests, Monocyte Activation Test (MAT), Recombinant C (RFC) Assay, and Rabbit Pyrogen Test), Application (Pharmaceutical Manufacturing, Medical Device Manufacturing, Raw Materials Production, and Packaging Manufacture), Method (Gel Clot Endotoxin and Pyrogen Test, Chromogenic Endotoxin and Pyrogen Test, and Turbidimetric Endotoxin and Pyrogen Test), Mode of Purchase (Large Group, Mid and Small Group, and Individual), End Product (Vaccines and/ Or CGT, Biologics, Injectable, and Others), End User (Pharmaceutical Companies, Biotechnology Companies, Biomedical Companies, Medical Device Companies, Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), and Others), Country (China, Japan, India, South Korea, Australia, Singapore, New Zealand, Indonesia, Philippines, Thailand, Malaysia, Vietnam, and rest of Asia-Pacific)- Industry Trends and Forecast to 2030

Overview of Asia-Pacific Endotoxin and Pyrogen Testing Market Dynamics


Driver
• Rapidly growing pharmaceutical and medical device industries

Restraint

• Strict regulatory guidelines

Opportunity

• Flourishing biopharmaceutical industry in developing countries

Market Players

Some of the major market players operating in the Asia-Pacific endotoxin and pyrogen testing market are:

• Pall Corporation (a subsidiary of Danaher)
• Thermo Fisher Scientific Inc.
• Charles River Laboratories
• Eurofins Scientific
• SGS SA
• Lonza
• WuXi AppTec
• Merck KGaA
• STERIS
• GenScript
• Sartorius AG
• InvivoGen
• Ellab A/S
• Nelson Laboratories, LLC
• bioMérieux SA
• HiMedia Laboratories
• FUJIFILM Wako Pure Chemical Corporation
• nanoComposix
• LifeSpan BioSciences, Inc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.